C4 Therapeutics Inc.

8-K

Presents Cemsidomide Phase 1 Data at the American Society for Hematology (ASH) Annual Meeting That Demonstrated Potential to Become Best-In-Class IKZF1/3 Degrader

12/09/24

8-K

Appoints Accomplished Oncology Executive Steve Hoerter to Board of Directors

11/20/24

424B3

Prospectus supplement

11/15/24

424B5

Prospectus supplement for primary offering

11/15/24

EFFECT

Notice of effectiveness

11/13/24

EFFECT

###### ## #############

11/13/24

SUPPL

############ ####

11/13/24

SUPPL

############ ####

11/13/24

CORRESP

############## #### ### ###

11/08/24

CORRESP

############## #### ### ###

11/08/24

UPLOAD

###### #### ### ###

11/07/24

UPLOAD

###### #### ### ###

11/07/24

S-3

##### ############

10/31/24

S-3

##### ############

10/31/24

10-Q

ended 12/34/56 ##

10/31/24

8-K

####### ##### ####### #### ######### ####### ### ###### ######## ##########

10/31/24

8-K/A

######## ##### ######## ###### ## ##### ########## ####### ### ######### ########## ## ####### ####### ####

10/16/24

8-K

######## ##### ######## ###### ## ##### ########## ####### ### ######### ########## ## ####### ####### ####

10/15/24

8-K

###### ## ########## ######## ## ############# ######### ########## ## ########

10/11/24

8-K

######## ####### ############# ###### ####### ####### ##### ## ##### ## #########

09/03/24

Search in Documents

Key Exhibits

External Links

Latest Filings – Non-Ownership Filter

Latest Filings – Ownership Filter

C4 Therapeutics Inc. Watch

Search in Documents

Key Exhibits

External Links

Latest Filings – Non-Ownership Filter

Latest Filings – Ownership Filter

C4 Therapeutics Inc.